Novartis announces the company’s fourth quarter and 2020 full year financial results.
Novartis maintained its position in the 2021 Access to Medicine Index, leading in its approach to product delivery, while performing strongly across all other areas of the Index.
Two Novartis leaders share their perspectives on digital health in 2020 – and the key trends to watch out for over the next 12 months.
Read and download the Annual Review, the Annual Report and Form 20-F, and the Novartis in Society ESG report.
Learn More
